Treating working memory deficits in schizophrenia: A review of the neurobiology

Biological Psychiatry

Volumn 75, Issue 5, 2014, Pages 361-370

  Lett, Tristram A ^a,b   Voineskos, Aristotle N ^a,b,c   Kennedy, James L ^a,b,c   Levine, Brian ^a,d   Daskalakis, Zafiris J ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Institute of Medical Science   (Canada)

^c Department of Psychiatry ^*  (Canada)

^d ROTMAN RESEARCH INSTITUTE   (Canada)

Author keywords

Cognition; EEG; neurophysiology; schizophrenia; TMS; working memory

Indexed keywords

CLOZAPINE; DIHYDREXIDINE; DOPAMINE; GALANTAMINE; HALOPERIDOL; MK 0777; NEUROLEPTIC AGENT; OLANZAPINE; TOLCAPONE; UNCLASSIFIED DRUG;

COGNITIVE THERAPY; DRUG TREATMENT FAILURE; HUMAN; MEMORY DISORDER; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROBIOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT PLANNING; WORKING MEMORY;

COGNITION; EEG; NEUROPHYSIOLOGY; SCHIZOPHRENIA; TMS; WORKING MEMORY;

HUMANS; MEMORY DISORDERS; MEMORY, SHORT-TERM; NEUROBIOLOGY; SCHIZOPHRENIA;

EID: 84893472659     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.07.026     Document Type: Review

References (150)

1. R.S. Keefe, R.M. Bilder, S.M. Davis, P.D. Harvey, B.W. Palmer, and J.M. Gold et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial Arch Gen Psychiatry 64 2007 633 647
2. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153 1996 321 330
3. J.M. Gold Cognitive deficits as treatment targets in schizophrenia Schizophr Res 72 2004 21 28
4. N. Barrantes-Vidal, M. Aguilera, S. Campanera, M. Fatjo-Vilas, M. Guitart, and S. Miret et al. Working memory in siblings of schizophrenia patients Schizophr Res 95 2007 70 75
5. A. Baddeley Working memory Science 255 1992 556 559
6. M.M. Mesulam From sensation to cognition Brain 121 1998 1013 1052
7. M. D'Esposito, B.R. Postle, and B. Rypma Prefrontal cortical contributions to working memory: Evidence from event-related fMRI studies Exp Brain Res 133 2000 3 11
8. J.H. Callicott, V.S. Mattay, B.A. Verchinski, S. Marenco, M.F. Egan, and D.R. Weinberger Complexity of prefrontal cortical dysfunction in schizophrenia: More than up or down Am J Psychiatry 160 2003 2209 2215
9. A. Meyer-Lindenberg, J.B. Poline, P.D. Kohn, J.L. Holt, M.F. Egan, and D.R. Weinberger et al. Evidence for abnormal cortical functional connectivity during working memory in schizophrenia Am J Psychiatry 158 2001 1809 1817
10. D.A. Lewis, and B. Moghaddam Cognitive dysfunction in schizophrenia: Convergence of gamma-aminobutyric acid and glutamate alterations Arch Neurol 63 2006 1372 1376
11. T. Pirkola, A. Tuulio-Henriksson, D. Glahn, T. Kieseppa, J. Haukka, and J. Kaprio et al. Spatial working memory function in twins with schizophrenia and bipolar disorder Biol Psychiatry 58 2005 930 936
12. T.A. Greenwood, D.L. Braff, G.A. Light, K.S. Cadenhead, M.E. Calkins, and D.J. Dobie et al. Initial heritability analyses of endophenotypic measures for schizophrenia: The consortium on the genetics of schizophrenia Arch Gen Psychiatry 64 2007 1242 1250
13. M. Petrides Specialized systems for the processing of mnemonic information within the primate frontal cortex Philos Trans R Soc Lond B Biol Sci 351 1996 1455 1461 discussion 1461-1452
14. P.S. Goldman-Rakic Regional and cellular fractionation of working memory Proc Natl Acad Sci U S A 93 1996 13473 13480
15. S. Funahashi, M.V. Chafee, and P.S. Goldman-Rakic Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task Nature 365 1993 753 756
16. F.A. Wilson, S.P. Scalaidhe, and P.S. Goldman-Rakic Dissociation of object and spatial processing domains in primate prefrontal cortex Science 260 1993 1955 1958
17. J.M. Fuster The Prefrontal Cortex 2008 Academic Press Boston
18. B.R. Postle Working memory as an emergent property of the mind and brain Neuroscience 139 2006 23 38
19. M. Corbetta, and G.L. Shulman Control of goal-directed and stimulus-driven attention in the brain Nat Rev Neurosci 3 2002 201 215
20. M.W. Cole, T. Yarkoni, G. Repovs, A. Anticevic, and T.S. Braver Global connectivity of prefrontal cortex predicts cognitive control and intelligence J Neurosci 32 2012 8988 8999
21. E.K. Miller, and J.D. Cohen An integrative theory of prefrontal cortex function Annu Rev Neurosci 24 2001 167 202
22. M. D'Esposito From cognitive to neural models of working memory Philos Trans R Soc Lond B Biol Sci 362 2007 761 772
23. P. Sauseng, W. Klimesch, M. Schabus, and M. Doppelmayr Fronto-parietal EEG coherence in theta and upper alpha reflect central executive functions of working memory Int J Psychophysiol 57 2005 97 103
24. L. Payne, and J. Kounios Coherent oscillatory networks supporting short-term memory retention Brain Res 1247 2009 126 132
25. F. Kopp, E. Schroger, and S. Lipka Synchronized brain activity during rehearsal and short-term memory disruption by irrelevant speech is affected by recall mode Int J Psychophysiol 61 2006 188 203
26. J. Sarnthein, H. Petsche, P. Rappelsberger, G.L. Shaw, and A. von Stein Synchronization between prefrontal and posterior association cortex during human working memory Proc Natl Acad Sci U S A 95 1998 7092 7096
27. P. Sauseng, W. Klimesch, M. Doppelmayr, S. Hanslmayr, M. Schabus, and W.R. Gruber Theta coupling in the human electroencephalogram during a working memory task Neurosci Lett 354 2004 123 126
28. N. Axmacher, M.M. Henseler, O. Jensen, I. Weinreich, C.E. Elger, and J. Fell Cross-frequency coupling supports multi-item working memory in the human hippocampus Proc Natl Acad Sci U S A 107 2010 3228 3233
29. R.K. Heaton, J.A. Gladsjo, B.W. Palmer, J. Kuck, T.D. Marcotte, and D.V. Jeste Stability and course of neuropsychological deficits in schizophrenia Arch Gen Psychiatry 58 2001 24 32
30. T.K. Rajji, Z. Ismail, and B.H. Mulsant Age at onset and cognition in schizophrenia: meta-analysis Br J Psychiatry 195 2009 286 293
31. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ (2009): Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology 23:315.
32. R.W. Heinrichs, and K.K. Zakzanis Neurocognitive deficit in schizophrenia: A quantitative review of the evidence Neuropsychology 12 1998 426 445
33. N.F. Forbes, L.A. Carrick, A.M. McIntosh, and S.M. Lawrie Working memory in schizophrenia: A meta-analysis Psychol Med 39 2009 889 905
34. D.S. Manoach Prefrontal cortex dysfunction during working memory performance in schizophrenia: Reconciling discrepant findings Schizophr Res 60 2003 285 298
35. D.R. Weinberger, K.F. Berman, and R.F. Zec Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence Arch Gen Psychiatry 43 1986 114 124
36. M.J. Minzenberg, A.R. Laird, S. Thelen, C.S. Carter, and D.C. Glahn Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia Arch Gen Psychiatry 66 2009 811 822
37. J. Bor, J. Brunelin, D. Sappey-Marinier, D. Ibarrola, T. d'Amato, and M.F. Suaud-Chagny et al. Thalamus abnormalities during working memory in schizophrenia. An fMRI study Schizophr Res 125 2011 49 53
38. K.E. Stephan, T. Baldeweg, and K.J. Friston Synaptic plasticity and dysconnection in schizophrenia Biol Psychiatry 59 2006 929 939
39. Y. Zhou, M. Liang, T. Jiang, L. Tian, Y. Liu, and Z. Liu et al. Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI Neurosci Lett 417 2007 297 302
40. N.D. Woodward, S.E. Purdon, H.Y. Meltzer, and D.H. Zald A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia Int J Neuropsychopharmacol 8 2005 457 472
41. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Arch Gen Psychiatry 45 1988 789 796
42. P.D. Harvey, E. Sacchetti, A. Galluzzo, F. Romeo, B. Gorini, and R.M. Bilder et al. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment Schizophr Res 105 2008 138 143
43. M.F. Green, K.H. Nuechterlein, J.M. Gold, D.M. Barch, J. Cohen, and S. Essock et al. Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria Biol Psychiatry 56 2004 301 307
44. R.W. Buchanan, R. Freedman, D.C. Javitt, A. Abi-Dargham, and J.A. Lieberman Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia Schizophr Bull 33 2007 1120 1130
45. D.M. Barch, and E. Smith The cognitive neuroscience of working memory: Relevance to CNTRICS and schizophrenia Biol Psychiatry 64 2008 11 17
46. S.A. Castner, G.V. Williams, and P.S. Goldman-Rakic Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation Science 287 2000 2020 2022
47. K.A. Dorph-Petersen, J.N. Pierri, J.M. Perel, Z. Sun, A.R. Sampson, and D.A. Lewis The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: A comparison of haloperidol and olanzapine in macaque monkeys Neuropsychopharmacology 30 2005 1649 1661
48. G.T. Konopaske, K.A. Dorph-Petersen, J.N. Pierri, Q. Wu, A.R. Sampson, and D.A. Lewis Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys Neuropsychopharmacology 32 2007 1216 1223
49. B.C. Ho, N.C. Andreasen, S. Ziebell, R. Pierson, and V. Magnotta Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia Arch Gen Psychiatry 68 2011 128 137
50. D.A. Lewis, and G. Gonzalez-Burgos Pathophysiologically based treatment interventions in schizophrenia Nat Med 12 2006 1016 1022
51. B. Moghaddam Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia Psychopharmacology (Berl) 174 2004 39 44
52. A.K. Malhotra, D.A. Pinals, C.M. Adler, I. Elman, A. Clifton, and D. Pickar et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics Neuropsychopharmacology 17 1997 141 150
53. T. Korotkova, E.C. Fuchs, A. Ponomarenko, J. von Engelhardt, and H. Monyer NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory Neuron 68 2010 557 569
54. M. Wang, Y. Yang, C.-J. Wang, N.J. Gamo, L.E. Jin, and J.A. Mazer et al. NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex Neuron 77 2013 736 749
55. R.W. Buchanan, D.C. Javitt, S.R. Marder, N.R. Schooler, J.M. Gold, and R.P. McMahon et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments Am J Psychiatry 164 2007 1593 1602
56. A. Abi-Dargham, O. Mawlawi, I. Lombardo, R. Gil, D. Martinez, and Y. Huang et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia J Neurosci 22 2002 3708 3719
57. A. Abi-Dargham, and H. Moore Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia Neuroscientist 9 2003 404 416
58. Q. Mu, K. Johnson, P.S. Morgan, E.L. Grenesko, C.E. Molnar, and B. Anderson et al. A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia Schizophr Res 94 2007 332 341
59. M.S. George, C.E. Molnar, E.L. Grenesko, B. Anderson, Q. Mu, and K. Johnson et al. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia Schizophr Res 93 2007 42 50
60. A. Meyer-Lindenberg, P.D. Kohn, B. Kolachana, S. Kippenhan, A. McInerney-Leo, and R. Nussbaum et al. Midbrain dopamine and prefrontal function in humans: Interaction and modulation by COMT genotype Nat Neurosci 8 2005 594 596
61. D.C. Goff, M. Hill, and D. Barch The treatment of cognitive impairment in schizophrenia Pharmacol Biochem Behav 99 2011 245 253
62. D.A. Lewis, D.W. Volk, and T. Hashimoto Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: A novel target for the treatment of working memory dysfunction Psychopharmacology (Berl) 174 2004 143 150
63. M.W. Howard, D.S. Rizzuto, J.B. Caplan, J.R. Madsen, J. Lisman, and R. Aschenbrenner-Scheibe et al. Gamma oscillations correlate with working memory load in humans Cereb Cortex 13 2003 1369 1374
64. E.F. Torrey, B.M. Barci, M.J. Webster, J.J. Bartko, J.H. Meador-Woodruff, and M.B. Knable Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains Biol Psychiatry 57 2005 252 260
65. D.A. Lewis, R.Y. Cho, C.S. Carter, K. Eklund, S. Forster, and M.A. Kelly et al. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia Am J Psychiatry 165 2008 1585 1593
66. R.W. Buchanan, R.S. Keefe, J.A. Lieberman, D.M. Barch, J.G. Csernansky, and D.C. Goff et al. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia Biol Psychiatry 69 2011 442 449
67. M.H. Schubert, K.A. Young, and P.B. Hicks Galantamine improves cognition in schizophrenic patients stabilized on risperidone Biol Psychiatry 60 2006 530 533
68. J. Singh, K. Kour, and M.B. Jayaram Acetylcholinesterase inhibitors for schizophrenia Cochrane Database Syst Rev 1 2012 CD007967
69. D.C. Javitt, R.W. Buchanan, R.S. Keefe, R. Kern, R.P. McMahon, and M.F. Green et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia Schizophr Res 136 2012 25 31
70. L.E. Hong, G.K. Thaker, R.P. McMahon, A. Summerfelt, J. Rachbeisel, and R.L. Fuller et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder Arch Gen Psychiatry 68 2011 1195 1206
71. M.S. Ritsner, A. Gibel, T. Shleifer, I. Boguslavsky, A. Zayed, and R. Maayan et al. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: An 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial J Clin Psychiatry 71 2010 1351 1362
72. M.M. McClure, P.D. Harvey, M. Goodman, J. Triebwasser, A. New, and H.W. Koenigsberg et al. Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: Continued evidence of the importance of the dopamine system in the schizophrenia spectrum Neuropsychopharmacology 35 2010 1356 1362
73. Y. Levkovitz, S. Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-Verbin, and G. Gal et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia J Clin Psychiatry 71 2010 138 149
74. D.M. Barch, and C.S. Carter Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers Schizophr Res 77 2005 43 58
75. H. Ehrenreich, D. Hinze-Selch, S. Stawicki, C. Aust, S. Knolle-Veentjer, and S. Wilms et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin Mol Psychiatry 12 2007 206 220
76. K.D. Cicerone, C. Dahlberg, J.F. Malec, D.M. Langenbahn, T. Felicetti, and S. Kneipp et al. Evidence-based cognitive rehabilitation: Updated review of the literature from 1998 through 2002 Arch Phys Med Rehabil 86 2005 1681 1692
77. T. Wykes, V. Huddy, C. Cellard, S.R. McGurk, and P. Czobor A meta-analysis of cognitive remediation for schizophrenia: Methodology and effect sizes Am J Psychiatry 168 2011 472 485
78. T. Wykes, M. Brammer, J. Mellers, P. Bray, C. Reeder, and C. Williams et al. Effects on the brain of a psychological treatment: Cognitive remediation therapy: Functional magnetic resonance imaging in schizophrenia Br J Psychiatry 181 2002 144 152
79. B.E. Wexler, M. Anderson, R.K. Fulbright, and J.C. Gore Preliminary evidence of improved verbal working memory performance and normalization of task-related frontal lobe activation in schizophrenia following cognitive exercises Am J Psychiatry 157 2000 1694 1697
80. G.E. Hogarty, S. Flesher, R. Ulrich, M. Carter, D. Greenwald, and M. Pogue-Geile et al. Cognitive enhancement therapy for schizophrenia: Effects of a 2-year randomized trial on cognition and behavior Arch Gen Psychiatry 61 2004 866 876
81. S.M. Eack, G.E. Hogarty, R.Y. Cho, K.M. Prasad, D.P. Greenwald, and S.S. Hogarty et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: Results from a 2-year randomized controlled trial Arch Gen Psychiatry 67 2010 674 682
82. T.A. Keller, and M.A. Just Altering cortical connectivity: Remediation-induced changes in the white matter of poor readers Neuron 64 2009 624 631
83. R. Penadés, N. Pujol, R. Catalán, G. Massana, G. Rametti, and C. García-Rizo et al. Brain effects of cognitive remediation therapy in schizophrenia: A structural and functional neuroimaging study Biol Psychiatry 73 2013 1015 1023
84. S.R. McGurk, E.W. Twamley, D.I. Sitzer, G.J. McHugo, and K.T. Mueser A meta-analysis of cognitive remediation in schizophrenia Am J Psychiatry 164 2007 1791 1802
85. S. Vinogradov, M. Fisher, and S. Nagarajan Cognitive training in schizophrenia: Golden age or wild west? Biol Psychiatry 73 2013 935 937
86. D. Dickinson, W. Tenhula, S. Morris, C. Brown, J. Peer, and K. Spencer et al. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia Am J Psychiatry 167 2010 170 180
87. R.A. Adcock, C. Dale, M. Fisher, S. Aldebot, A. Genevsky, and G.V. Simpson et al. When top-down meets bottom-up: Auditory training enhances verbal memory in schizophrenia Schizophr Bull 35 2009 1132 1141
88. M. Fisher, C. Holland, M.M. Merzenich, and S. Vinogradov Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia Am J Psychiatry 166 2009 805 811
89. M. Fisher, C. Holland, K. Subramaniam, and S. Vinogradov Neuroplasticity-based cognitive training in schizophrenia: An interim report on the effects 6 months later Schizophr Bull 36 2010 869 879
90. N.V. Murthy, H. Mahncke, B.E. Wexler, P. Maruff, A. Inamdar, and M. Zucchetto et al. Computerized cognitive remediation training for schizophrenia: An open label, multi-site, multinational methodology study Schizophr Res 139 2012 87 91
91. M. Hallett Transcranial magnetic stimulation and the human brain Nature 406 2000 147 150
92. S. Rossi, S.F. Cappa, C. Babiloni, P. Pasqualetti, C. Miniussi, and F. Carducci et al. Prefrontal [correction of Prefontal] cortex in long-term memory: An "interference" approach using magnetic stimulation Nat Neurosci 4 2001 948 952
93. L. Rami, A. Gironell, J. Kulisevsky, C. Garcia-Sanchez, M. Berthier, and A. Estevez-Gonzalez Effects of repetitive transcranial magnetic stimulation on memory subtypes: A controlled study Neuropsychologia 41 2003 1877 1883
94. F.M. Mottaghy, R. Sparing, and R. Topper Enhancing picture naming with transcranial magnetic stimulation Behav Neurol 17 2006 177 186
95. S.F. Cappa, M. Sandrini, P.M. Rossini, K. Sosta, and C. Miniussi The role of the left frontal lobe in action naming: rTMS evidence Neurology 59 2002 720 723
96. B. Boroojerdi, M. Phipps, L. Kopylev, C.M. Wharton, L.G. Cohen, and J. Grafman Enhancing analogic reasoning with rTMS over the left prefrontal cortex Neurology 56 2001 526 528
97. M. Hansenne, O. Laloyaux, S. Mardaga, and M. Ansseau Impact of low frequency transcranial magnetic stimulation on event-related brain potentials Biol Psychol 67 2004 331 341
98. P.M. Rossini, and S. Rossi Transcranial magnetic stimulation Neurology 68 2007 484 488
99. N.C. Rogasch, and P.B. Fitzgerald Assessing cortical network properties using TMS-EEG Hum Brain Mapp 34 2013 1652 1669
100. Z.J. Daskalakis, F. Farzan, M.S. Barr, P.M. Rusjan, G. Favalli, and A.J. Levinson et al. Evaluating the relationship between long interval cortical inhibition, working memory and gamma band activity in the dorsolateral prefrontal cortex Clin EEG Neurosci 39 2008 150 155
101. S.S. Hoppenbrouwers, D.R. De Jesus, T. Stirpe, P.B. Fitzgerald, A.N. Voineskos, and D.J.L.G. Schutter et al. Inhibitory deficits in the dorsolateral prefrontal cortex in psychopathic offenders Cortex 49 2013 1377 1385
102. Z.J. Daskalakis, F. Farzan, M.S. Barr, J.J. Maller, R. Chen, and P.B. Fitzgerald Long-interval cortical inhibition from the dorsolateral prefrontal cortex: A TMS-EEG study Neuropsychopharmacology 33 2008 2860 2869
103. P.J. Uhlhaas, and W. Singer Abnormal neural oscillations and synchrony in schizophrenia Nat Rev Neurosci 11 2010 100 113
104. G.A. Light, J.L. Hsu, M.H. Hsieh, K. Meyer-Gomes, J. Sprock, and N.R. Swerdlow et al. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients Biol Psychiatry 60 2006 1231 1240
105. F. Farzan, M.S. Barr, A.J. Levinson, R. Chen, W. Wong, and P.B. Fitzgerald et al. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia Brain 133 2010 1505 1514
106. K. Kirihara, A.J. Rissling, N.R. Swerdlow, D.L. Braff, and G.A. Light Hierarchical organization of gamma and theta oscillatory dynamics in schizophrenia Biol Psychiatry 71 2012 873 880
107. R.Y. Cho, R.O. Konecky, and C.S. Carter Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia Proc Natl Acad Sci U S A 103 2006 19878 19883
108. C.S. Herrmann, M.H. Munk, and A.K. Engel Cognitive functions of gamma-band activity: Memory match and utilization Trends Cogn Sci 8 2004 347 355
109. M. Bartos, I. Vida, and P. Jonas Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks Nat Rev Neurosci 8 2007 45 56
110. R.T. Canolty, E. Edwards, S.S. Dalal, M. Soltani, S.S. Nagarajan, and H.E. Kirsch et al. High gamma power is phase-locked to theta oscillations in human neocortex Science 313 2006 1626 1628
111. E. Papp, X. Leinekugel, D.A. Henze, J. Lee, and G. Buzsaki The apical shaft of CA1 pyramidal cells is under GABAergic interneuronal control Neuroscience 102 2001 715 721
112. V.S. Sohal, F. Zhang, O. Yizhar, and K. Deisseroth Parvalbumin neurons and gamma rhythms enhance cortical circuit performance Nature 459 2009 698 702
113. M.S. Barr, F. Farzan, L.C. Tran, R. Chen, P.B. Fitzgerald, and Z.J. Daskalakis Evidence for excessive frontal evoked gamma oscillatory activity in schizophrenia during working memory Schizophr Res 121 2010 146 152
114. C. Haenschel, R.A. Bittner, J. Waltz, F. Haertling, M. Wibral, and W. Singer et al. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia J Neurosci 29 2009 9481 9489
115. G.W. Thickbroom Transcranial magnetic stimulation and synaptic plasticity: Experimental framework and human models Exp Brain Res 180 2007 583 593
116. R. Chen, J. Classen, C. Gerloff, P. Celnik, E.M. Wassermann, and M. Hallett et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation Neurology 48 1997 1398 1403
117. A. Pascual-Leone, J. Valls-Sole, E.M. Wassermann, and M. Hallett Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex Brain 117 1994 847 858
118. U. Ziemann, W. Paulus, M.A. Nitsche, A. Pascual-Leone, W.D. Byblow, and A. Berardelli et al. Consensus: Motor cortex plasticity protocols Brain Stimul 1 2008 164 182
119. T.K. Rajji, S.K. Liu, M.V. Frantseva, B.H. Mulsant, J. Thoma, and R. Chen et al. Exploring the effect of inducing long-term potentiation in the human motor cortex on motor learning Brain Stimul 4 2011 137 144
120. A. Benali, J. Trippe, E. Weiler, A. Mix, E. Petrasch-Parwez, and W. Girzalsky et al. Theta-burst transcranial magnetic stimulation alters cortical inhibition J Neurosci 31 2011 1193 1203
121. Y.Z. Huang, M.J. Edwards, E. Rounis, K.P. Bhatia, and J.C. Rothwell Theta burst stimulation of the human motor cortex Neuron 45 2005 201 206
122. W. Pettersson-Yeo, P. Allen, S. Benetti, P. McGuire, and A. Mechelli Dysconnectivity in schizophrenia: Where are we now? Neurosci Biobehav Rev 35 2011 1110 1124
123. A.S. Meyer-Lindenberg, R.K. Olsen, P.D. Kohn, T. Brown, M.F. Egan, and D.R. Weinberger et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia Arch Gen Psychiatry 62 2005 379 386
124. K.M. Spencer, P.G. Nestor, M.A. Niznikiewicz, D.F. Salisbury, M.E. Shenton, and R.W. McCarley Abnormal neural synchrony in schizophrenia J Neurosci 23 2003 7407 7411
125. A.N. Voineskos, N.J. Lobaugh, S. Bouix, T.K. Rajji, D. Miranda, and J.L. Kennedy et al. Diffusion tensor tractography findings in schizophrenia across the adult lifespan Brain 133 2010 1494 1504
126. M. Kubicki, H. Park, C.F. Westin, P.G. Nestor, R.V. Mulkern, and S.E. Maier et al. DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity Neuroimage 26 2005 1109 1118
127. I. Sommer, N. Ramsey, R. Kahn, A. Aleman, and A. Bouma Handedness, language lateralisation and anatomical asymmetry in schizophrenia: Meta-analysis Br J Psychiatry 178 2001 344 351
128. S. Kapur Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia Am J Psychiatry 160 2003 13 23
129. L.A. Glantz, and D.A. Lewis Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia Arch Gen Psychiatry 57 2000 65 73
130. M. Ayalew, H. Le-Niculescu, D.F. Levey, N. Jain, B. Changala, and S.D. Patel et al. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction Mol Psychiatry 17 2012 887 905
131. Lett TA, Chakavarty MM, Felsky D, Brandl EJ, Tiwari AK, Goncalves VF, et al. (2013): The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry 18:443-450.
132. H.Y. Tan, W.C. Choo, C.S. Fones, and M.W. Chee fMRI study of maintenance and manipulation processes within working memory in first-episode schizophrenia Am J Psychiatry 162 2005 1849 1858
133. M.S. Barr, F. Farzan, T. Arenovich, R. Chen, P.B. Fitzgerald, and Z.J. Daskalakis The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia PLoS One 6 2011 e22627
134. S.W. Flavell, and M.E. Greenberg Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system Annu Rev Neurosci 31 2008 563
135. K. Deisseroth, H. Bito, and R.W. Tsien Signaling from synapse to nucleus: Postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity Neuron 16 1996 89 101
136. R.R. Ji, T.E. Schlaepfer, C.D. Aizenman, C.M. Epstein, D. Qiu, and J.C. Huang et al. Repetitive transcranial magnetic stimulation activates specific regions in rat brain Proc Natl Acad Sci U S A 95 1998 15635 15640
137. X. Tao, S. Finkbeiner, D.B. Arnold, A.J. Shaywitz, and M.E. Greenberg Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism Neuron 20 1998 709 726
138. D. Muller, Z. Djebbara-Hannas, P. Jourdain, L. Vutskits, P. Durbec, and G. Rougon et al. Brain-derived neurotrophic factor restores long-term potentiation in polysialic acid-neural cell adhesion molecule-deficient hippocampus Proc Natl Acad Sci U S A 97 2000 4315 4320
139. J. Hellmann, R. Juttner, C. Roth, M. Bajbouj, I. Kirste, and I. Heuser et al. Repetitive magnetic stimulation of human-derived neuron-like cells activates cAMP-CREB pathway Eur Arch Psychiatry Clin Neurosci 262 2012 87 91
140. N. Vo, M.E. Klein, O. Varlamova, D.M. Keller, T. Yamamoto, and R.H. Goodman et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis Proc Natl Acad Sci U S A 102 2005 16426 16431
141. G.A. Wayman, M. Davare, H. Ando, D. Fortin, O. Varlamova, and H.Y. Cheng et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP Proc Natl Acad Sci U S A 105 2008 9093 9098
142. B.H. Miller, Z. Zeier, L. Xi, T.A. Lanz, S. Deng, and J. Strathmann et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function Proc Natl Acad Sci U S A 109 2012 3125 3130
143. M.S. Barr, F. Farzan, T.K. Rajji, A.N. Voineskos, D.M. Blumberger, and T. Arenovich et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial Biol Psychiatry 73 2013 510 517
144. B. Guse, P. Falkai, O. Gruber, H. Whalley, L. Gibson, and A. Hasan et al. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls-A randomized placebo-controlled, double-blind fMRI study Behav Brain Res 237C 2012 300 307
145. K.S. Utz, V. Dimova, K. Oppenlander, and G. Kerkhoff Electrified minds: Transcranial direct current stimulation (tDCS) and galvanic vestibular stimulation (GVS) as methods of non-invasive brain stimulation in neuropsychology - a review of current data and future implications Neuropsychologia 48 2010 2789 2810
146. P.G. Mulquiney, K.E. Hoy, Z.J. Daskalakis, and P.B. Fitzgerald Improving working memory: Exploring the effect of transcranial random noise stimulation and transcranial direct current stimulation on the dorsolateral prefrontal cortex Clin Neurophysiol 122 2011 2384 2389
147. R. Polania, M.A. Nitsche, C. Korman, G. Batsikadze, and W. Paulus The importance of timing in segregated theta phase-coupling for cognitive performance Curr Biol 22 2012 1314 1318
148. B. Guse, P. Falkai, and T. Wobrock Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: A systematic review J Neural Transm 117 2010 105 122
149. J.E. Lisman, J.T. Coyle, R.W. Green, D.C. Javitt, F.M. Benes, and S. Heckers et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia Trends Neurosci 31 2008 234 242
150. Barr MS, Farzan F, Rusjan PM, Chen R, Fitzgerald PB, Daskalakis ZJ (2009): Potentiation of gamma oscillatory activity through repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuropsychopharmacology 34:2359-2367